Industry Partners
The SVS VQI works closely with industry using real-world registry data to advance the understanding of devices and therapies, improve patient safety, and streamline development.
Retrospective and Prospective Projects: Manufacturers can use the SVS VQI for retrospective or prospective projects to evaluate devices and therapies, working with the SVS PSO, FDA and Fivos:
- Take advantage of the existing network of over 850 SVS VQI centers participating in SVS VQI
- Reduce costs by simplifying site contracting, avoiding IRB fees
- Create dynamic content on the Fivos PATHWAYS web-based platform
- Supplement existing data with required elements to greatly speed project completion and meet regulatory requirements
- Provided necessary comparative device data as opposed to prospectively collecting this data over an estimated three years
Please see the latest documents describing industry projects:
- WEBINAR: Leveraging Real World Evidence Using the Vascular Quality Initiative
- 2021 SVS VQI Annual Report
- 2020 SVS VQI Annual Report
- Data Sharing Proposal Form
- Industry Overview
- SVS VQI Post-Approval Surveillance Process